Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-01-07 @ 8:24 PM
Study NCT ID:
NCT01602003
Status:
COMPLETED
Last Update Posted:
2012-05-18
First Post:
2012-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
Sponsor:
LG Life Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-15
First Submit QC Date:
None
Study First Post Date:
2012-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-17
Last Update Post Date:
2012-05-18
Last Update Post Date Type:
ESTIMATED